These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 34666104)

  • 21. Unique N-terminal extension domain of human asparaginyl-tRNA synthetase elicits CCR3-mediated chemokine activity.
    Park JS; Park MC; Lee KY; Goughnour PC; Jeong SJ; Kim HS; Kim HJ; Lee BJ; Kim S; Han BW
    Int J Biol Macromol; 2018 Dec; 120(Pt A):835-845. PubMed ID: 30171954
    [TBL] [Abstract][Full Text] [Related]  

  • 22. UDP-galactopyranose mutase, a potential drug target against human pathogenic nematode Brugia malayi.
    Misra S; Valicherla GR; Mohd Shahab ; Gupta J; Gayen JR; Misra-Bhattacharya S
    Pathog Dis; 2016 Aug; 74(6):. PubMed ID: 27465638
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of anti-filarial leads against aspartate semialdehyde dehydrogenase of Wolbachia endosymbiont of Brugia malayi: combined molecular docking and molecular dynamics approaches.
    Amala M; Rajamanikandan S; Prabhu D; Surekha K; Jeyakanthan J
    J Biomol Struct Dyn; 2019 Feb; 37(2):394-410. PubMed ID: 29334340
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drug targets for lymphatic filariasis: a bioinformatics approach.
    Sharma OP; Vadlamudi Y; Kota AG; Sinha VK; Kumar MS
    J Vector Borne Dis; 2013 Sep; 50(3):155-62. PubMed ID: 24220073
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Discovering new classes of Brugia malayi asparaginyl-tRNA synthetase inhibitors and relating specificity to conformational change.
    Sukuru SC; Crepin T; Milev Y; Marsh LC; Hill JB; Anderson RJ; Morris JC; Rohatgi A; O'Mahony G; Grøtli M; Danel F; Page MG; Härtlein M; Cusack S; Kron MA; Kuhn LA
    J Comput Aided Mol Des; 2006 Mar; 20(3):159-78. PubMed ID: 16645791
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Brugia malayi infection in ferrets - A small mammal model of lymphatic filariasis.
    Jackson-Thompson BM; Kim SY; Jaiswal S; Scott JR; Jones SR; Morris CP; Fite JJ; Laurie K; Hoy AR; Dardzinski BJ; Mitre E
    PLoS Negl Trop Dis; 2018 Mar; 12(3):e0006334. PubMed ID: 29601572
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Yeast-Based High-Throughput Screens to Identify Novel Compounds Active against Brugia malayi.
    Bilsland E; Bean DM; Devaney E; Oliver SG
    PLoS Negl Trop Dis; 2016 Jan; 10(1):e0004401. PubMed ID: 26812604
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An Insight into the Discovery of Potent Antifilarial Leads Against Lymphatic Filariasis.
    Boniface PK; Elizabeth FI
    Curr Drug Targets; 2020; 21(7):657-680. PubMed ID: 31800381
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Humans from Wuchereria bancrofti endemic area elicit substantial immune response to proteins of the filarial parasite Brugia malayi and its endosymbiont Wolbachia.
    Jha R; Gangwar M; Chahar D; Setty Balakrishnan A; Negi MP; Misra-Bhattacharya S
    Parasit Vectors; 2017 Jan; 10(1):40. PubMed ID: 28118850
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antifilarial drugs, in the doses employed in mass drug administrations by the Global Programme to Eliminate Lymphatic Filariasis, reverse lymphatic pathology in children with Brugia malayi infection.
    Shenoy RK; Suma TK; Kumaraswami V; Rahmah N; Dhananjayan G; Padma S
    Ann Trop Med Parasitol; 2009 Apr; 103(3):235-47. PubMed ID: 19341538
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic trial of doxycyclin plus ivermectin for the treatment of Brugia malayi naturally infected cats.
    Khowawisetsut L; Sarasombath PT; Thammapalo S; Loymek S; Korbarsa T; Nochote H; Phuakrod A; Choochote W; Wongkamchai S
    Vet Parasitol; 2017 Oct; 245():42-47. PubMed ID: 28969836
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dual RNAseq analyses at soma and germline levels reveal evolutionary innovations in the elephantiasis-agent Brugia malayi, and adaptation of its Wolbachia endosymbionts.
    Chevignon G; Foray V; Pérez-Jiménez MM; Libro S; Chung M; Foster JM; Landmann F
    PLoS Negl Trop Dis; 2021 Jan; 15(1):e0008935. PubMed ID: 33406151
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Solution structure of the N-terminal extension domain of a
    Peck Y; Pickering D; Mobli M; Liddell MJ; Wilson DT; Ruscher R; Ryan S; Buitrago G; McHugh C; Love NC; Pinlac T; Haertlein M; Kron MA; Loukas A; Daly NL
    J Biomol Struct Dyn; 2024 Sep; 42(15):7934-7944. PubMed ID: 37572327
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular Characterization of a Reemergent
    Mallawarachchi CH; Chandrasena TGAN; Withanage GP; Premarathna R; Mallawarachchi SMNSM; Gunawardane NY; Dasanayake RS; Gunarathna D; de Silva NR
    Biomed Res Int; 2021; 2021():9926101. PubMed ID: 34414239
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human cytosolic asparaginyl-tRNA synthetase: cDNA sequence, functional expression in Escherichia coli and characterization as human autoantigen.
    Beaulande M; Tarbouriech N; Härtlein M
    Nucleic Acids Res; 1998 Jan; 26(2):521-4. PubMed ID: 9421509
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular characterization of NAD+-dependent DNA ligase from Wolbachia endosymbiont of lymphatic filarial parasite Brugia malayi.
    Shrivastava N; Nag JK; Misra-Bhattacharya S
    PLoS One; 2012; 7(7):e41113. PubMed ID: 22815933
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and antifilarial activity of chalcone-thiazole derivatives against a human lymphatic filarial parasite, Brugia malayi.
    Sashidhara KV; Rao KB; Kushwaha V; Modukuri RK; Verma R; Murthy PK
    Eur J Med Chem; 2014 Jun; 81():473-80. PubMed ID: 24863844
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Troponin 1 of human filarial parasite Brugia malayi: cDNA cloning, expression, purification, and its immunoprophylactic potential.
    Kushwaha V; Tewari P; Mandal P; Tripathi A; Murthy PK
    Parasitol Res; 2019 Jun; 118(6):1849-1863. PubMed ID: 31055672
    [TBL] [Abstract][Full Text] [Related]  

  • 39. How Thailand eliminated lymphatic filariasis as a public health problem.
    Rojanapanus S; Toothong T; Boondej P; Thammapalo S; Khuanyoung N; Santabutr W; Prempree P; Gopinath D; Ramaiah KD
    Infect Dis Poverty; 2019 May; 8(1):38. PubMed ID: 31130143
    [TBL] [Abstract][Full Text] [Related]  

  • 40. RNAi-based discovery and validation of new drug targets in filarial nematodes.
    Behm CA; Bendig MM; McCarter JP; Sluder AE
    Trends Parasitol; 2005 Mar; 21(3):97-100. PubMed ID: 15734653
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.